Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roca, C.
Right arrow Articles by Bussolino, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roca, C.
Right arrow Articles by Bussolino, F.
[Cancer Research 63, 1500-1507, April 1, 2003]
© 2003 American Association for Cancer Research


Experimental Therapeutics

Hyperthermia Inhibits Angiogenesis by a Plasminogen Activator Inhibitor 1-dependent Mechanism1

Cristina Roca, Luca Primo2, Donatella Valdembri, Anna Cividalli, Paul Declerck, Peter Carmeliet, Pietro Gabriele and Federico Bussolino

Division of Molecular Angiogenesis, Institute for Cancer Research and Treatment (IRCC), and Department of Oncological Sciences, School of Medicine, University of Torino, 10060 Candiolo, Italy [C. R., L. P., D. V., F. B.]; Division of Radiotherapy, IRCC, Ordine Mauriziano, 10060 Candiolo, Italy [P. G.]; Division of Medicine and Biomedicine, ENEA CR Casaccia, 00060 Rome, Italy [A. C.]; Laboratory for Pharmaceutical Biology and Phytopharmacology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium [P. D.]; and Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium [P. C.]

Hyperthermia (HT) associated with radiotherapy or chemotherapy is a promising method for cancer treatment, although the molecular mechanisms of this process are not well understood. HT exhibits various antitumor effects, including damage of tumor vasculature. Here, we investigate the effect of HT on in vitro and in vivo angiogenesis. We show that heat treatment of endothelial cells (ECs) affect their differentiation into capillary-like structures in two models of in vitro angiogenesis. Furthermore, the formation of new vessels promoted by angiogenic inducers in the chick embryo chorioallantoic membrane assay is impaired after heat treatment. These effects cannot be explained by direct cytotoxicity but are dependent on modulation of angiogenesis-involved genes. Gene expression profile of ECs subjected to heat shock demonstrates that plasminogen activator inhibitor 1 (PAI-1), a protein involved in the control of extracellular matrix degradation, is specifically up-regulated. The use of anti-PAI-1-neutralizing antibodies reverts the effect of HT on the in vitro EC morphogenesis and in vivo vessel formation. Moreover, microvessel outgrowth from PAI-1-/- aortic rings was not affected by HT compared with aortic rings from PAI-1+/+ mice. Heat treatment of murine mammary adenocarcinomas results in inhibition of tumor growth, associated with a reduction of microvessel number and an increase of PAI-1 expression. These results indicate that heat-mediated PAI-1 induction is an important pathway by which HT exerts its antitumor activity and may represent a rationale for a combined cancer therapy based on HT associated with antiangiogenic molecules.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Subramaniam, C. Bausch, A. Twomey, S. Andreeva, B. A. Yoder, L. Chang, J. D. Crapo, R. A. Pierce, F. Cuttitta, and M. E. Sunday
Bombesin-like Peptides Modulate Alveolarization and Angiogenesis in Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med., November 1, 2007; 176(9): 902 - 912.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
X. Liang, T. Kanjanabuch, S.-L. Mao, C.-M. Hao, Y.-W. Tang, P. J. Declerck, A. H. Hasty, D. H. Wasserman, A. B. Fogo, and L.-J. Ma
Plasminogen activator inhibitor-1 modulates adipocyte differentiation
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E103 - E113.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Buchwalter, C. Gross, and B. Wasylyk
The Ternary Complex Factor Net Regulates Cell Migration through Inhibition of PAI-1 Expression
Mol. Cell. Biol., December 15, 2005; 25(24): 10853 - 10862.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Gallicchio, S. Mitola, D. Valdembri, R. Fantozzi, B. Varnum, G. C. Avanzi, and F. Bussolino
Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor
Blood, March 1, 2005; 105(5): 1970 - 1976.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Audero, I. Cascone, F. Maniero, L. Napione, M. Arese, L. Lanfrancone, and F. Bussolino
Adaptor ShcA Protein Binds Tyrosine Kinase Tie2 Receptor and Regulates Migration and Sprouting but Not Survival of Endothelial Cells
J. Biol. Chem., March 26, 2004; 279(13): 13224 - 13233.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Strasly, G. Doronzo, P. Capello, D. Valdembri, M. Arese, S. Mitola, P. Moore, G. Alessandri, M. Giovarelli, and F. Bussolino
CCL16 activates an angiogenic program in vascular endothelial cells
Blood, January 1, 2004; 103(1): 40 - 49.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Cascone, E. Giraudo, F. Caccavari, L. Napione, E. Bertotti, J. G. Collard, G. Serini, and F. Bussolino
Temporal and Spatial Modulation of Rho GTPases during in Vitro Formation of Capillary Vascular Network: ADHERENS JUNCTIONS AND MYOSIN LIGHT CHAIN AS TARGETS OF Rac1 AND RhoA
J. Biol. Chem., December 12, 2003; 278(50): 50702 - 50713.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.